The biosocial dynamics of tuberculosis

Tropical Medicine and International Health

Volumn 14, Issue 2, 2009, Pages 124-130

  Grange, John M ^a   Kapata, Nathan ^b   Chanda, Duncan ^c   Mwaba, Peter ^c   Zumla, Alimuddin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MINISTRY OF HEALTH   (Zambia)

^c UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

Control; Drug resistance; Economic; Epidemic; History; Social; Tuberculosis

Indexed keywords

AMINOSALICYLIC ACID; ISONIAZID; PATULIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULIN; TUBERCULOSTATIC AGENT;

COST-BENEFIT ANALYSIS; DISEASE CONTROL; DISEASE TREATMENT; DRUG RESISTANCE; EPIDEMIC; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ATTITUDE TO HEALTH; CAUSE OF DEATH; CLINICAL TRIAL; COMMUNITY CARE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVELOPING COUNTRY; EPIDEMIC; EVIDENCE BASED MEDICINE; FUNDING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE SUSTAINING TREATMENT; LUNG COLLAPSE; LUNG TUBERCULOSIS; MIXED INFECTION; MULTIDRUG RESISTANCE; PREVALENCE; PUBLIC HEALTH; REVIEW; SHORT COURSE THERAPY; SOCIOECONOMICS; TREATMENT RESPONSE; TREND STUDY; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ANTITUBERCULAR AGENTS; DISEASE OUTBREAKS; EVIDENCE-BASED MEDICINE; HIV INFECTIONS; HUMANS; SOCIOECONOMIC FACTORS; TUBERCULOSIS; WORLD HEALTH;

EID: 60349120480     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02205.x     Document Type: Review

References (47)

1. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G Tugela Ferry Care and Research (TF CARES) Collaboration (2007) Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Journal of Infectious Diseases 196 (Suppl. 3 S482 490.
2. Ball P (2006) The Devil's Doctor. Paracelsus and the World of Renaissance Magic and Science. Heinemann, London.
3. Bhatti N, Law MR, Morris JK, Halliday R Moore-Gillon J (1995) Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. British Medical Journal 310, 967 969.
4. Black D (1998) The limitations of evidence. Journal of the Royal College of Physicians 32, 23 26.
5. Brudney K Dobkin J (1991) Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness and the decline of tuberculosis control programmes. The American Review of Respiratory Disease 144, 745 749.
6. Christie DA Tansey EM (eds) (2005) Short-Course Chemotherapy for Tuberculosis. Wellcome Witnesses to Twentieth Century Medicine, Vol. 24. Wellcome Trust Centre for the History of Medicine at UCL, London.
7. Cohen-Kohler JC (2008) The morally uncomfortable global drug gap. Clinical Pharmacology and Therapeutics 84, 23.
8. Collins CH Grange JM (1983) The bovine tubercle bacillus. Journal of Applied Bacteriology 55, 13 29.
9. Comstock GW (1980) Advances toward the conquest of tuberculosis. Public Health Reports 95, 444 450.
10. Crawfurd R (1911) The King's Evil. Clarenden Press, Oxford.
11. Davies PDO Grange JM (2001) The genetics of resistance and susceptibility to tuberculosis. Annals of the New York Academy of Science 953, 151 156.
12. Farmer P (1997) Social scientists and the new tuberculosis. Social Science and Medicine 44, 347 358.
13. Farmer P Nardell E (1998) Nihilism and pragmatism in tuberculosis control. American Journal of Public Health 88, 1014 1015.
14. Floyd K Pantoja A (2008) Financial resources required for tuberculosis control to achieve global targets set for 2015. Bulletin of the World Health Organization 86, 568 576.
15. Francis J (1959) The work of the British Royal Commission on Tuberculosis, 1901-1911. Tubercle 40, 124 132.
16. Grange JM Bishop PJ (1982) "Über Tuberculose". A tribute to Robert Koch's discovery of the tubercle bacillus, 1882. Tubercle 63, 3 17.
17. Grange JM Festenstein F (1993) The human dimension of tuberculosis control. Tubercle and Lung Disease 74, 219 222.
18. Grange JM, Gandy M, Farmer P Zumla A (2001a) Historical declines in tuberculosis - nature, nurture and the biosocial model. The International Journal of Tuberculosis and Lung Disease 3, 208 212.
19. Grange JM, Story A Zumla A (2001b) Tuberculosis in disadvantaged groups. Current Opinion in Pulmonary Medicine 7, 160 164.
20. Kaufmann SH Parida SK (2007) Changing funding patterns in tuberculosis. Nature Medicine 13, 299 303.
21. Koenig R (2008) Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination. Science 319, 894 897.
22. Maher D, Dye C, Floyd K et al. (2007) Planning to improve global health: the next decade of tuberculosis control. Bulletin of the World Health Organization 85, 341 347.
23. Mangtani P, Jolley DJ, Watson JM Rodrigues LC (1995) Socioeconomic deprivation and notification rates for tuberculosis in London during 1982-91. British Medical Journal 310, 963 966.
24. McKeown T Record RG (1962) Reasons for the decline in mortality in England and Wales in the nineteenth century. Population Studies 16, 94 122.
25. Medical Research Council (1948) Streptomycin treatment of pulmonary tuberculosis. A Medical Research Council investigation. British Medical Journal ii, 769 782.
26. Medical Research Council (1955) Various combinations of isoniazid with streptomycin or with PAS in the treatment of pulmonary tuberculosis. British Medical Journal i, 435 445.
27. Medical Research Council Patulin Clinical Trials Committee (1944) Clinical trials of patulin in the common cold. Lancet ii, 373 375.
28. Moore-Gillon J (1998) Tuberculosis and poverty in the developed world. In : Clinical Tuberculosis, 2nd edn (ed. PDO Davies) Chapman and Hall, London, pp. 383 393.
29. Mullan Z Zumla A (2006) New global efforts for containing the White Plague - turning the tide against tuberculosis. Lancet 367, 877 878.
30. Narayan T Narayan R (1999) Educational approaches in tuberculosis control: building on the 'social' paradigm. In : Tuberculosis - An Interdisciplinary Perspective (eds JDH Porter JM Grange) Imperial College Press, London, pp. 489 509.
31. Porter JDH Grange JM, eds 1999) Tuberculosis - An Interdisciplinary Perspective. Imperial College Press, London.
32. Raviglione MC (2007) The new stop TB strategy and the global plan to stop TB, 2006-2015. Bulletin of the World Health Organization 85, 327.
33. Reichman LB (1991) The U-shaped curve of concern. The American Review of Respiratory Disease 144, 741 742.
34. Reichman LB (1997) Tuberculosis elimination - what's to stop us? The International Journal of Tuberculosis and Lung Disease 1, 3 11.
35. Rook GAW (2007) Stop TB: a long way to go, but new twists and turns in the science. Indian Journal of Medical Sciences 125, 109 111.
36. Rubel AJ Garro LC (1992) Social and cultural factors in the successful control of tuberculosis. Public Health Reports 107, 626 636.
37. Ryan F (1992) The Greatest Story Never Told. Bromsgrove, Swift.
38. Sbabaro J (1991) Patient compliance with preventive therapy. Operational considerations. Bulletin of the International Union against Tuberculosis and Lung Disease 66 (Suppl. 37 39.
39. Spence DP, Hotchkiss J, Williams CS Davies PD (1993) Tuberculosis and poverty. British Medical Journal 307, 759 761.
40. Sreenu VB, Kumar P, Nagaraju J Nagarajaram HA (2006) Microsatellite polymorphism across the M. tuberculosis and M. bovis genomes: implications on genome evolution and plasticity. BMC Genomics 7, 78 (Epub).
41. Toungoussova OS, Caugant DA, Sandven P et al. (2004) Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunology and Medical Microbiology 42, 281 290.
42. Williams L (1908) The worship of Moloch. British Journal of Tuberculosis 2, 56 62.
43. World Health Organization (1994) TB - A Global Emergency. World Health Organization. (WHO/TB/94.177), Geneva.
44. World Health Organization (2005) Global Drug Facility. Sustaining the Gains. National Self Sufficiency for TB Drug Access. A Global Drug Facility Strategy. WHO, Geneva.
45. World Health Organization (2008) Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report. (WHO/HTM/TB/2008.393) World Health Organization, Geneva.
46. Zumla A (2008) Tuberculosis: the tide can be turned, the battle can be won. Journal of the Royal Society of Medicine 101, 100 101.
47. Zumla A Grange JM (1999) The 'global emergency' of tuberculosis. The Journal of the Royal College of Physicians of Edinburg 29, 104 115.